A Systematic Review for Variables to Be Collected in a Transplant Database for Improving Risk Prediction.


Journal

Transplantation
ISSN: 1534-6080
Titre abrégé: Transplantation
Pays: United States
ID NLM: 0132144

Informations de publication

Date de publication:
12 2019
Historique:
pubmed: 16 2 2019
medline: 12 6 2020
entrez: 16 2 2019
Statut: ppublish

Résumé

This systematic review was commissioned to identify new variables associated with transplant outcomes that are not currently collected by the Organ Procurement and Transplantation Network (OPTN). We identified 81 unique studies including 1 193 410 patients with median follow-up of 36 months posttransplant, reporting 108 unique risk factors. Most risk factors (104) were recipient related; few (4) were donor related. Most risk factors were judged to be practical and feasible to routinely collect. Relative association measures were small to moderate for most risk factors (ranging between 1.0 and 2.0). The strongest relative association measure for a heart transplant outcome with a risk factor was 8.6 (recipient with the previous Fontan operation), for a kidney transplant 2.8 (sickle cell nephropathy as primary cause of end-stage renal disease), for a liver transplant 14.3 (recipient serum ferritin >500 µg/L), and for a lung transplant 6.3 (Burkholderia cepacia complex infection for 1 y or less). OPTN may consider some of these 108 variables for future collection to enhance transplant research and clinical care. Evidence-based approaches can be used to determine variables collected in databases and registries. Several candidate variables have been identified for OPTN.

Sections du résumé

BACKGROUND
This systematic review was commissioned to identify new variables associated with transplant outcomes that are not currently collected by the Organ Procurement and Transplantation Network (OPTN).
METHODS
We identified 81 unique studies including 1 193 410 patients with median follow-up of 36 months posttransplant, reporting 108 unique risk factors.
RESULTS
Most risk factors (104) were recipient related; few (4) were donor related. Most risk factors were judged to be practical and feasible to routinely collect. Relative association measures were small to moderate for most risk factors (ranging between 1.0 and 2.0). The strongest relative association measure for a heart transplant outcome with a risk factor was 8.6 (recipient with the previous Fontan operation), for a kidney transplant 2.8 (sickle cell nephropathy as primary cause of end-stage renal disease), for a liver transplant 14.3 (recipient serum ferritin >500 µg/L), and for a lung transplant 6.3 (Burkholderia cepacia complex infection for 1 y or less). OPTN may consider some of these 108 variables for future collection to enhance transplant research and clinical care.
CONCLUSIONS
Evidence-based approaches can be used to determine variables collected in databases and registries. Several candidate variables have been identified for OPTN.

Identifiants

pubmed: 30768569
doi: 10.1097/TP.0000000000002652
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, P.H.S. Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2591-2601

Subventions

Organisme : AHRQ HHS
ID : R01 HS024527
Pays : United States

Auteurs

Jehad Almasri (J)

Evidence-Based Practice Research Program, Mayo Clinic, MN.
Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, MN.

Mouaffaa Tello (M)

Evidence-Based Practice Research Program, Mayo Clinic, MN.
Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, MN.

Raed Benkhadra (R)

Evidence-Based Practice Research Program, Mayo Clinic, MN.
Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, MN.

Allison S Morrow (AS)

Evidence-Based Practice Research Program, Mayo Clinic, MN.
Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, MN.

Bashar Hasan (B)

Evidence-Based Practice Research Program, Mayo Clinic, MN.
Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, MN.

Wigdan Farah (W)

Evidence-Based Practice Research Program, Mayo Clinic, MN.
Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, MN.

Neri Alvarez Villalobos (N)

Evidence-Based Practice Research Program, Mayo Clinic, MN.
Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, MN.

Khaled Mohammed (K)

Evidence-Based Practice Research Program, Mayo Clinic, MN.
Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, MN.

Jay-Sheree P Allen (JP)

Evidence-Based Practice Research Program, Mayo Clinic, MN.
Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, MN.

Larry J Prokop (LJ)

Mayo Clinic Libraries, Mayo Clinic, Rochester, MN.

Zhen Wang (Z)

Evidence-Based Practice Research Program, Mayo Clinic, MN.
Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, MN.

Bertram L Kasiske (BL)

Scientific Registry of Transplant Recipients, Minneapolis Medical Research Foundation, Minneapolis, MN.
Department of Medicine, Hennepin Healthcare, University of Minnesota, Minneapolis, MN.

Mohammad Hassan Murad (MH)

Evidence-Based Practice Research Program, Mayo Clinic, MN.
Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, MN.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH